LobbyingBiotechnology Innovation Organization lobbying by quarter
Biotechnology Innovation Organization's latest lobbying report covers Q2 2026, at $50K. The four quarters Q4 2025–Q3 2026 total $150K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Medicare/Medicaid.
Biotechnology Innovation Organization
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $150K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $50K | 1 |
| Q1 2023 | $50K | 1 |
| Q2 2023 | $50K | 1 |
| Q3 2023 | $50K | 1 |
| Q4 2023 | $50K | 1 |
| Q1 2024 | $50K | 1 |
| Q2 2024 | $50K | 1 |
| Q3 2024 | $50K | 1 |
| Q4 2024 | $140K | 1 |
| Q1 2025 | $140K | 1 |
| Q2 2025 | $50K | 1 |
| Q3 2025 | $50K | 1 |
| Q4 2025 | $50K | 1 |
| Q1 2026 | $50K | 1 |
| Q2 2026 | $50K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$198.5K · 15 reports
- Medicare and Medicaid$198.5K · 15 reports
- Taxation$198.5K · 15 reports
- Trade$198.5K · 15 reports
- Health issues$136K · 10 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
- Executive Office of the President (EOP)5 reports
- Food & Drug Administration (FDA)5 reports
- Health & Human Services, Dept of (HHS)5 reports
Firms it paid
| Firm | ||
|---|---|---|
| Capitol Counsel | $930K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| KAREN STONE | Office of former Congressman Steve Israel (D-NY) [Legislative Correspondent/Staff Assistant, 2005; Senior Legislative Assistant, 2005-2009] Office of Congresswoman Dina Titus (D-NV) [Legislative Director, 2009-2010]. | Q4 2025 |
| CHARLES PATRICK MICHAELS | Chief of Staff, Deputy Chief of Staff, Legislative Director, Senior Legislative Assistant, and Legislative Assistant, Rep. David Schweikert; Staff Assistant, Rep. Ted Budd; Intern, Senator James DeMint. | Q2 2025 |
| ADAM LEONARD CARASSO | Senior Tax and Economic Advisor, Senate Finance Committee; Chief Economist, House Budget Committee. | Q4 2024 |
| JOHN MARTIN | Principal Associate Commissioner, FDA; Legislative Director, Sen. Tom Cotton; Legislative Assistant; Sen. Tom Cotton; Legislative Assistant, Representative Tom Cotton. | Q1 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/16for Q2 | Capitol Counsel | $50K |
| 04/18for Q1 | Capitol Counsel | $50K |
| 01/18for Q4 2025 | Capitol Counsel | $50K |
| 25/10/17for Q3 2025 | Capitol Counsel | $50K |
| 25/07/21for Q2 2025 | Capitol Counsel | $50K |
| 25/04/18for Q1 2025 | Capitol Counsel | $140K |
| 25/01/21for Q4 2024 | Capitol Counsel | $140K |
| 24/10/19for Q3 2024 | Capitol Counsel | $50K |
| 24/07/19for Q2 2024 | Capitol Counsel | $50K |
| 24/04/19for Q1 2024 | Capitol Counsel | $50K |
| 24/01/22for Q4 2023 | Capitol Counsel | $50K |
| 23/10/18for Q3 2023 | Capitol Counsel | $50K |
| 23/07/17for Q2 2023 | Capitol Counsel | $50K |
| 23/04/17for Q1 2023 | Capitol Counsel | $50K |
| 23/04/17for Q4 2022 | Capitol Counsel | $50K |
| 23/01/18for Q4 2022 | Capitol Counsel | $50K |